reviewTop 1% cited
Glia and their cytokines in progression of neurodegeneration
Neurobiology of Aging · 2004 · Vol. 26(3) · pp. 349–354
Robert E. Mrak(University of Arkansas for Medical Sciences)W. Sue T. Griffin✉(Central Arkansas Veterans Healthcare System)
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsS100 Proteins and AnnexinsNeurodegenerationMicrogliaDiseasePresenilinAlzheimer's diseaseDown syndromeNeuroscienceDegenerative diseaseDementiaBiology
MeSH terms
AgingAlzheimer DiseaseAnimalsBrainDown SyndromeHumansNeurogliaCytokinesNeurodegenerative DiseasesMiceRats
Funding
- Donald W. Reynolds Foundation
- Institut National de la Santé et de la Recherche Médicale
- National Institutes of Health
- National Health and Medical Research Council
Citations
585
FWCI
13.07
field-weighted impact
References
61
Percentile
99%
vs. same field & year
Citations per year
Cited by
Excitotoxicity: Bridge to various triggers in neurodegenerative disorders
European Journal of Pharmacology · 2012 · 659 citations
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
Experimental Neurology · 2007 · 596 citations
Inflammasomes in neuroinflammation and changes in brain function: a focused review
Frontiers in Neuroscience · 2014 · 367 citations
Microglia Function in Alzheimer’s Disease
Frontiers in Pharmacology · 2012 · 353 citations
References
Glial cytokines in Alzheimer's disease: Review and pathogenic implications
Human Pathology · 1995 · 418 citations
Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome
Annals of Neurology · 1985 · 1,160 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.